Results 311 to 320 of about 616,611 (358)
Some of the next articles are maybe not open access.
Current Treatment Options in Gastroenterology, 2004
Interferon alpha, lamivudine, and adefovir are the three drugs currently approved for the treatment of chronic hepatitis B virus (HBV). There are pros and cons associated with the use of each drug. Individualization of therapy, based upon factors such as patient comorbidities, response to prior therapies, and stage of disease, is recommended.
Stephanie D, Straley, Norah A, Terrault
openaire +2 more sources
Interferon alpha, lamivudine, and adefovir are the three drugs currently approved for the treatment of chronic hepatitis B virus (HBV). There are pros and cons associated with the use of each drug. Individualization of therapy, based upon factors such as patient comorbidities, response to prior therapies, and stage of disease, is recommended.
Stephanie D, Straley, Norah A, Terrault
openaire +2 more sources
Virchows Archiv A Pathological Anatomy and Histology, 1974
A type of chronic hepatitis designated as chronic septal hepatitis was distinguished morphologically from chronic aggressive and chronic persistent hepatitis: 18 cases were separated from chronic aggressive hepatitis by the absence of destruction and inflammatory infiltration of the limiting plate and from chronic persistent hepatitis by the presence ...
M A, Gerber, S, Vernace
openaire +2 more sources
A type of chronic hepatitis designated as chronic septal hepatitis was distinguished morphologically from chronic aggressive and chronic persistent hepatitis: 18 cases were separated from chronic aggressive hepatitis by the absence of destruction and inflammatory infiltration of the limiting plate and from chronic persistent hepatitis by the presence ...
M A, Gerber, S, Vernace
openaire +2 more sources
The American Journal of Digestive Diseases, 1964
The etiology of chronic persistent hepatitis is not known. The evidence to date supports the view that subacute hepatic necrosis, rather than the ordinary epidemic viral hepatitis, can and does progress into chronic persistent hepatitis and postnecrotic cirrhosis. Glucocorticoid therapy results in clinical and biochemical improvements. If its long-term
openaire +2 more sources
The etiology of chronic persistent hepatitis is not known. The evidence to date supports the view that subacute hepatic necrosis, rather than the ordinary epidemic viral hepatitis, can and does progress into chronic persistent hepatitis and postnecrotic cirrhosis. Glucocorticoid therapy results in clinical and biochemical improvements. If its long-term
openaire +2 more sources
The Indian Journal of Pediatrics, 1995
Among hepatitis A to E viruses, hepatitis B, C, and D viruses can cause chronic hepatitis, in both children and adults. Hepatitis B virus (HBV) infection is the most prevalent and important one. Perinatal transmission accounts for about 40-45% of chronic HBV infection in hyperendemic areas.
openaire +2 more sources
Among hepatitis A to E viruses, hepatitis B, C, and D viruses can cause chronic hepatitis, in both children and adults. Hepatitis B virus (HBV) infection is the most prevalent and important one. Perinatal transmission accounts for about 40-45% of chronic HBV infection in hyperendemic areas.
openaire +2 more sources
Southern Medical Journal, 1997
Infection with the hepatitis C virus (HCV) is a leading cause of chronic liver disease worldwide. Epidemiologic and natural history studies have helped to define the clinical impact of HCV infection, and molecular diagnostic assays have established clinical endpoints against which therapeutic regimens are currently tested.
openaire +2 more sources
Infection with the hepatitis C virus (HCV) is a leading cause of chronic liver disease worldwide. Epidemiologic and natural history studies have helped to define the clinical impact of HCV infection, and molecular diagnostic assays have established clinical endpoints against which therapeutic regimens are currently tested.
openaire +2 more sources
2019
The objective of this chapter is to provide a comprehensive synthesis of current knowledge on epidemiology, natural history, treatment and outcomes of paediatric chronic hepatitis B and C. Hepatitis B virus is a leading cause of morbidity and mortality worldwide.
Indolfi G., D'Antiga L.
openaire +2 more sources
The objective of this chapter is to provide a comprehensive synthesis of current knowledge on epidemiology, natural history, treatment and outcomes of paediatric chronic hepatitis B and C. Hepatitis B virus is a leading cause of morbidity and mortality worldwide.
Indolfi G., D'Antiga L.
openaire +2 more sources
Journal of Pediatric Gastroenterology and Nutrition, 2008
Michelle E. Freshman +1 more
openaire +3 more sources
Michelle E. Freshman +1 more
openaire +3 more sources
Annals of Internal Medicine, 1988
Excerpt To the Editor:Perrillo and colleagues (1) make an important contribution to the study of chronic hepatitis B treatment.
openaire +2 more sources
Excerpt To the Editor:Perrillo and colleagues (1) make an important contribution to the study of chronic hepatitis B treatment.
openaire +2 more sources
Drug-Induced Chronic Hepatitis
Springer Seminars in Immunopathology, 1980Many drugs can produce hepatic damage, either as the result of a direct toxic effect on the liver which is dose-dependent or as an unpredictable effect which may or may not be a true drug hypersensitivity. When due to a direct hepatotoxin, hepatocellular necrosis varying in severity will be produced.
openaire +2 more sources
Chronic Persistent Hepatitis and Chronic Lobular Hepatitis
1989Chronic persistent hepatitis (CPH) and chronic lobular hepatitis belong to the clinicopathologic spectrum of chronic hepatitis. Both have a benign connotation in the sense that they do not progress, by definition, to serious forms of chronic liver diseases, e.g., chronic active hepatitis and cirrhosis.
Jorge Rakela, Jurgen Ludwig
openaire +1 more source